Both in R&D — Physical & Biological Sciences
bioAffinity Technologies vs MaxCyte
Over the past year BIAF returned −91.6% and MXCT returned +10.3%; their daily moves had a correlation of 0.01.
BIAF −91.6% MXCT +10.3%Growth of $1, one year, split-adjusted
| Metric | BIAF | MXCT |
|---|---|---|
| Price | $3.14 | $1.71 |
| Market cap | $1.9M | $176.5M |
| Today | +6.08% | +11.04% |
| 1 month | −54.4% | +44.9% |
| 6 months | −91.4% | +109.1% |
| Year to date | −82.3% | +10.3% |
| 1 year | −91.9% | +11.0% |
| Revenue growth (YoY) | +19.0% | −14.5% |
| Gross margin | 100.0% | 77.0% |
| Net margin | −222.8% | −122.0% |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | 5.7× |
| Net cash | $1.8M | $105.7M |
| Dividend yield | — | — |
| Volatility (60d) | 825.7% | 78.8% |
| Short % of float | 11.4% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).